Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a report issued on Wednesday, ...

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research ...

GSK PLC GSK shares inched up 0.03% to £14.97 Thursday, on what proved to be an all-around favorable trading session for the ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.

GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...

The Boston Globe reports on findings from researchers at Mass General Brigham who examined "reservoirs" of the covid virus that hide inside people after their acute infections have ended. Also in the ...